HIV-1 inhibitor-38
HIV-1 inhibitor-38 (Compound 91) is a potent HIV-1. HIV-1 inhibitor-38 has the potential for further development as novel latency reversing agents[1].
Product Specifications
CAS Number
2416971-48-5
UNSPSC
12352005
Target
HIV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/hiv-1-inhibitor-38.html
Solubility
10 mM in DMSO
Smiles
ClC1=CC2=C(NC(N3CCN(CC3)C4=CN=C(C(Cl)=C4)Cl)=N2)N=C1
Molecular Formula
C15H13Cl3N6
Molecular Weight
383.66
References & Citations
[1]Nguyen W, et al. Optimization of 5-substituted thiazolyl ureas and 6-substituted imidazopyridines as potential HIV-1 latency reversing agents. Eur J Med Chem. 2020 Jun 1;195:112254.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
HIV-1
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC681081-500 1x 500 µL
CD45RO (190-2F2.5), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC472748-500 1x 500 µL
AMACR / p504S (Prostate Cancer Marker) (AMACR/2748R), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470857-100 1x 100 µL
WT1 (Wilm's Tumor 1) (WT1/857), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401237-500 1x 500 µL
P27 / KIP1 (DCS-72.F6 + KIP1/769 (SX53G8) ), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details